ReGen Biologics Inc.
OTC: RGBOQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- William G. Rodkey D.V.M.
- Employees
- 15
- Headquarters
- Hackensack, United States
- IPO year
- 1996
- Market cap
- $97.0
Loading RGBOQ…
Loading profile data…Frequently asked questions about RGBOQ
What does ReGen Biologics Inc. (RGBOQ) do?
ReGen Biologics Inc., established in 1987 and headquartered in Hackensack, New Jersey, specialized in the development, manufacturing, and commercialization of medical devices. These devices were engineered for the restoration and growth of soft human tissues, particularly within orthopedic fields. The company's core asset was its unique collagen...
Where does RGBOQ trade?
ReGen Biologics Inc. (RGBOQ) trades on the Other OTC.
What sector is RGBOQ in?
ReGen Biologics Inc. (RGBOQ) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of ReGen Biologics Inc.?
William G. Rodkey D.V.M. is the chief executive officer of ReGen Biologics Inc. (RGBOQ).
Where is ReGen Biologics Inc. headquartered?
ReGen Biologics Inc. is headquartered in United States.
Does RGBOQ pay a dividend?
ReGen Biologics Inc. (RGBOQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RGBOQ go public?
ReGen Biologics Inc. (RGBOQ) completed its initial public offering in 1996.